• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弗林特动物癌症中心(FACC)犬肿瘤细胞系面板:兽医药物发现、比较肿瘤学和转化医学的资源。

The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.

机构信息

Cell and Molecular Biology Program, Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA.

Flint Animal Cancer Center, Veterinary Medical Center, Colorado State University, Fort Collins, CO, USA.

出版信息

Vet Comp Oncol. 2017 Jun;15(2):481-492. doi: 10.1111/vco.12192. Epub 2016 May 19.

DOI:10.1111/vco.12192
PMID:27197945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5656225/
Abstract

Mammalian cell tissue culture has been a critical tool leading to our current understanding of cancer including many aspects of cellular transformation, growth and response to therapies. The current use of large panels of cell lines with associated phenotypic and genotypic information now allows for informatics approaches and in silico screens to rapidly test hypotheses based on simple as well as complex relationships. Current cell line panels with large amounts of associated drug sensitivity and genomics data are comprised of human cancer cell lines (i.e. NCI60 and GDSC). There is increased recognition of the contribution of canine cancer to comparative cancer research as a spontaneous large animal model with application in basic and translational studies. We have assembled a panel of canine cancer cell lines to facilitate studies in canine cancer and report here phenotypic and genotypic data associated with these cells.

摘要

哺乳动物细胞组织培养一直是我们目前对癌症的理解的重要工具,包括细胞转化、生长和对治疗反应的许多方面。目前使用具有表型和基因型信息的大量细胞系面板,现在允许基于简单和复杂关系的信息学方法和计算机屏幕快速测试假设。目前包含大量相关药物敏感性和基因组学数据的细胞系面板由人类癌细胞系(即 NCI60 和 GDSC)组成。人们越来越认识到犬类癌症作为一种具有基础和转化研究应用的自发大型动物模型对比较癌症研究的贡献。我们已经组装了一组犬癌细胞系,以促进犬类癌症的研究,并在此报告与这些细胞相关的表型和基因型数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ab/5656225/1c35fef16d5a/nihms871585f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ab/5656225/4367c20a3971/nihms871585f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ab/5656225/183e1426aafe/nihms871585f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ab/5656225/44e259a9d1fd/nihms871585f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ab/5656225/1c35fef16d5a/nihms871585f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ab/5656225/4367c20a3971/nihms871585f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ab/5656225/183e1426aafe/nihms871585f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ab/5656225/44e259a9d1fd/nihms871585f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ab/5656225/1c35fef16d5a/nihms871585f4.jpg

相似文献

1
The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.弗林特动物癌症中心(FACC)犬肿瘤细胞系面板:兽医药物发现、比较肿瘤学和转化医学的资源。
Vet Comp Oncol. 2017 Jun;15(2):481-492. doi: 10.1111/vco.12192. Epub 2016 May 19.
2
JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.JFCR39,一个由 39 个人类癌细胞系组成的面板,及其在抗癌药物的发现和开发中的应用。
Bioorg Med Chem. 2012 Mar 15;20(6):1947-51. doi: 10.1016/j.bmc.2012.01.017. Epub 2012 Jan 21.
3
Cancer and comparative imaging.癌症与对比成像
ILAR J. 2014;55(1):164-8. doi: 10.1093/ilar/ilu014.
4
Clinical, Pathological, and Ethical Considerations for the Conduct of Clinical Trials in Dogs with Naturally Occurring Cancer: A Comparative Approach to Accelerate Translational Drug Development.对患有自然发生癌症的犬类进行临床试验的临床、病理和伦理考量:加速转化药物开发的比较方法
ILAR J. 2018 Dec 1;59(1):99-110. doi: 10.1093/ilar/ily019.
5
Modernizing the NCI60 Cell Line Screen for Phenotypic Drug Discovery in the 21st Century.在 21 世纪实现 NCI60 细胞系筛选的现代化,以进行表型药物发现。
Cancer Res. 2024 Aug 1;84(15):2397-2399. doi: 10.1158/0008-5472.CAN-24-1506.
6
Current Trends in Drug Sensitivity Prediction.药物敏感性预测的当前趋势
Curr Pharm Des. 2016;22(46):6918-6927. doi: 10.2174/1381612822666161026154430.
7
A novel canine kidney cell line model for the evaluation of neoplastic development: karyotype evolution associated with spontaneous immortalization and tumorigenicity.一种用于评估肿瘤发生的新型犬肾细胞系模型:与自发永生化和致瘤性相关的核型演变
Chromosome Res. 2015 Dec;23(4):663-80. doi: 10.1007/s10577-015-9474-8. Epub 2015 May 10.
8
Comparative oncology: what dogs and other species can teach us about humans with cancer.比较肿瘤学:狗和其他物种能让我们了解患癌人类的哪些方面。
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 19;370(1673). doi: 10.1098/rstb.2014.0231.
9
Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines.非甾体抗炎药对一组犬癌细胞系直接抗肿瘤作用的分子研究。
Vet J. 2017 Mar;221:38-47. doi: 10.1016/j.tvjl.2017.02.001. Epub 2017 Feb 3.
10
Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine.功能基因组图谱的异常值分析丰富了肿瘤学靶点,并推动了精准医学的发展。
BMC Genomics. 2016 Jun 13;17:455. doi: 10.1186/s12864-016-2807-y.

引用本文的文献

1
Capacity for Compensatory Cyclin D2 Response Confers Trametinib Resistance in Canine Mucosal Melanoma.代偿性细胞周期蛋白D2反应能力赋予犬黏膜黑色素瘤对曲美替尼的耐药性。
Cancers (Basel). 2025 Jul 15;17(14):2357. doi: 10.3390/cancers17142357.
2
Capacity for compensatory cyclin D2 response confers trametinib resistance in canine mucosal melanoma.代偿性细胞周期蛋白D2反应能力赋予犬黏膜黑色素瘤对曲美替尼的抗性。
bioRxiv. 2025 Apr 26:2025.04.24.650512. doi: 10.1101/2025.04.24.650512.
3
Melittin inhibits proliferation, migration, and invasion in osteosarcoma cell lines using 2D and 3D models.

本文引用的文献

1
limma powers differential expression analyses for RNA-sequencing and microarray studies.limma为RNA测序和微阵列研究提供差异表达分析的动力。
Nucleic Acids Res. 2015 Apr 20;43(7):e47. doi: 10.1093/nar/gkv007. Epub 2015 Jan 20.
2
Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo.一种具有体内转移能力的新型原发性肝癌细胞系的建立与鉴定
Cancer Cell Int. 2014 Oct 9;14(1):103. doi: 10.1186/s12935-014-0103-y. eCollection 2014.
3
Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor.
蜂毒肽使用二维和三维模型抑制骨肉瘤细胞系的增殖、迁移和侵袭。
J Venom Anim Toxins Incl Trop Dis. 2025 Apr 14;31:e20240053. doi: 10.1590/1678-9199-JVATITD-2024-0053. eCollection 2025.
4
Epigenetic regulation in muscle-invasive urothelial carcinoma of the bladder in the dog, a translational model of human cancer.犬膀胱肌层浸润性尿路上皮癌中的表观遗传调控,一种人类癌症的转化模型。
Vet Oncol. 2024;1. doi: 10.1186/s44356-024-00011-2. Epub 2024 Nov 20.
5
VDX-111 targets proliferative pathways in canine cancer cell lines.VDX-111 靶向犬科癌细胞系中的增殖途径。
PLoS One. 2024 May 21;19(5):e0303470. doi: 10.1371/journal.pone.0303470. eCollection 2024.
6
Validation of ferroptosis in canine cancer cells to enable comparative oncology and translational medicine.犬癌细胞中铁死亡的验证,以推动比较肿瘤学和转化医学发展。
bioRxiv. 2024 Apr 30:2024.04.28.591561. doi: 10.1101/2024.04.28.591561.
7
Bringing the Genomic Revolution to Comparative Oncology: Human and Dog Cancers.将基因组革命引入比较肿瘤学:人类癌症和犬类癌症。
Annu Rev Biomed Data Sci. 2024 Aug;7(1):107-129. doi: 10.1146/annurev-biodatasci-102423-111936. Epub 2024 Jul 24.
8
Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity.用犬源 B7-H3 CAR T 细胞靶向治疗骨肉瘤及 CXCR2 共表达对功能活性的影响。
Cancer Immunol Immunother. 2024 Mar 30;73(5):77. doi: 10.1007/s00262-024-03642-4.
9
Editorial: Canine osteosarcoma as a model in comparative oncology: Advances and perspective.社论:犬骨肉瘤作为比较肿瘤学的模型:进展与展望
Front Vet Sci. 2023 Jan 31;10:1141666. doi: 10.3389/fvets.2023.1141666. eCollection 2023.
10
Nanocarriers in Veterinary Medicine: A Challenge for Improving Osteosarcoma Conventional Treatments.兽医学中的纳米载体:改善骨肉瘤传统治疗方法面临的一项挑战。
Nanomaterials (Basel). 2022 Dec 19;12(24):4501. doi: 10.3390/nano12244501.
犬肥大细胞瘤中对磷酸托西拉尼(Palladia®)获得性耐药的体外模型的建立。
BMC Vet Res. 2014 May 6;10:105. doi: 10.1186/1746-6148-10-105.
4
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.癌症药物敏感性基因组学(GDSC):癌症细胞治疗生物标志物发现的资源。
Nucleic Acids Res. 2013 Jan;41(Database issue):D955-61. doi: 10.1093/nar/gks1111. Epub 2012 Nov 23.
5
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.癌症细胞系百科全书使对抗癌药物敏感性的预测建模成为可能。
Nature. 2012 Mar 28;483(7391):603-7. doi: 10.1038/nature11003.
6
Drug discovery: Cell lines battle cancer.药物研发:细胞系对抗癌症。
Nature. 2012 Mar 28;483(7391):544-5. doi: 10.1038/483544a.
7
ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.ETV1、4和5:ETS转录因子的一个致癌亚家族。
Biochim Biophys Acta. 2012 Aug;1826(1):1-12. doi: 10.1016/j.bbcan.2012.02.002. Epub 2012 Mar 8.
8
Reading between the lines: molecular characterization of five widely used canine lymphoid tumour cell lines.字里行间的解读:五种常用犬淋巴样肿瘤细胞系的分子特征分析。
Vet Comp Oncol. 2013 Mar;11(1):30-50. doi: 10.1111/j.1476-5829.2011.00299.x. Epub 2011 Nov 23.
9
Polymerase chain reaction-based species verification and microsatellite analysis for canine cell line validation.基于聚合酶链反应的犬细胞系验证的物种鉴定及微卫星分析
J Vet Diagn Invest. 2011 Jul;23(4):780-5. doi: 10.1177/1040638711408064. Epub 2011 Jun 13.
10
Epidermal growth factor enhances the malignant phenotype in canine mammary carcinoma cell lines.表皮生长因子增强犬乳腺肿瘤细胞系的恶性表型。
Vet Comp Oncol. 2011 Sep;9(3):196-206. doi: 10.1111/j.1476-5829.2010.00248.x. Epub 2010 Nov 22.